Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

China flag China · Delayed Price · Currency is CNY
17.07
-0.41 (-2.35%)
Mar 4, 2026, 3:04 PM CST
0.89%
Market Cap 20.07B
Revenue (ttm) 10.50B
Net Income (ttm) 861.74M
Shares Out 1.15B
EPS (ttm) 0.75
PE Ratio 23.45
Forward PE 13.98
Dividend 0.35 (1.99%)
Ex-Dividend Date Sep 17, 2025
Volume 6,643,960
Average Volume 8,491,725
Open 18.16
Previous Close 17.48
Day's Range 17.02 - 18.16
52-Week Range 12.96 - 19.59
Beta 0.41
RSI 41.59
Earnings Date Mar 20, 2026

About SHE:000739

Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. It operates through API, CDMO, and Pharmaceutical segments. The company offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other... [Read more]

Sector Healthcare
Founded 1989
Employees 7,060
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000739
Full Company Profile

Financial Performance

In 2024, SHE:000739's revenue was 12.02 billion, an increase of 4.77% compared to the previous year's 11.47 billion. Earnings were 1.03 billion, a decrease of -2.29%.

Financial Statements

News

There is no news available yet.